Clinical Trials Directory

Trials / Completed

CompletedNCT06661616

Cognitive Effects Associated With Hippocampal Neurogenesis Induced by ECT in the Treatment of Depression

Cognitive Effects Associated With Hippocampal Neurogenesis Induced by Electroconvulsive Therapy in the Treatment of Depression

Status
Completed
Phase
Study type
Observational
Enrollment
87 (actual)
Sponsor
Centre Hospitalier St Anne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Electroconvulsive therapy (ECT) is the treatment of choice for drug-resistant depression (30% of patients), or when there is a short-term risk to the patient's life. Despite its robust efficacy and rapid onset of action, its use is limited both by the limited range of treatment available and by the cognitive effects sometimes induced. The present study focuses on the links between the efficacy of ECT, its cognitive effects and the formation of new neurons in the hippocampus (hippocampal neurogenesis) associated with this treatment.

Conditions

Timeline

Start date
2018-06-06
Primary completion
2024-05-14
Completion
2024-05-14
First posted
2024-10-28
Last updated
2024-10-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06661616. Inclusion in this directory is not an endorsement.